HomeAI · summaries
Storia in 7 fonti
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
axios.com
Eli Lilly agrees to $3.8B psychedelic buy
The AtaiBeckley acquisition would be the largest psychedelic deal to date.
- ·
benzinga.com
AtaiBeckley Shares Surge as Eli Lilly Seals $3.8B Acquisition Deal - Eli Lilly (NYSE:LLY), AtaiBeckley (N
Lilly will acquire AtaiBeckley in a deal worth up to $3.8 billion, adding late-stage depression therapies to its mental health pipeline.
